Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Valvular Heart Disease

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 51 articles: HTML format Text format

Single Articles

June 2018
1. COLLET JP, Berti S, Cequier A, Van Belle E, et al
   Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial.
   Am Heart J. 2018;200:44-50.
   PubMed     Text format     Abstract available
   
   
   
2. STEINVIL A, Buchanan KD, Kiramijyan S, Bond E, et al
   Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement.
   Am Heart J. 2018;200:11-16.
   PubMed     Text format     Abstract available
   
   
   May 2018
3. SHIBATA K, Yamamoto M, Kano S, Koyama Y, et al
   Importance of Geriatric Nutritional Risk Index assessment in patients undergoing transcatheter aortic valve replacement.
   Am Heart J. 2018;202:68-75.
   PubMed     Text format     Abstract available
   
   
   
4. CZARNECKI A, Qiu F, Koh M, Alter DA, et al
   Trends in the incidence and outcomes of patients with aortic stenosis hospitalization.
   Am Heart J. 2018;199:144-149.
   PubMed     Text format     Abstract available
   
   
   April 2018
5. EL-HARASIS MA, Connolly HM, Miranda WR, Qureshi MY, et al
   Progressive right ventricular enlargement due to pulmonary regurgitation: Clinical characteristics of a "low-risk" group.
   Am Heart J. 2018;201:136-140.
   PubMed     Text format     Abstract available
   
   
   
6. GALPER BZ, Beery DE, Leighton G, Englander LL, et al
   Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance data.
   Am Heart J. 2018;198:64-74.
   PubMed     Text format     Abstract available
   
   
   March 2018
7. FANNING JP, Wesley AJ, Walters DL, Wong AA, et al
   Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation.
   Am Heart J. 2018;197:113-123.
   PubMed     Text format     Abstract available
   
   
   February 2018
8. BUCHANAN KD, Rogers T, Alraies MC, Steinvil A, et al
   Temporal trends in patient referral for Transcatheter aortic valve replacement and reasons for exclusion at a high-volume Center in the United States.
   Am Heart J. 2018;196:74-81.
   PubMed     Text format     Abstract available
   
   
   January 2018
9. VEMULAPALLI S, Holmes DR Jr, Dai D, Matsouaka R, et al
   Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
   Am Heart J. 2018;195:1-13.
   PubMed     Text format     Abstract available
   
   
   
10. BANOVIC M, Iung B, Bartunek J, Penicka M, et al
    The Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A protocol update.
    Am Heart J. 2018;195:153-154.
    PubMed     Text format    
    
    
    December 2017
11. BARON SJ, Arnold SV, Reynolds MR, Wang K, et al
    Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
    Am Heart J. 2017;194:39-48.
    PubMed     Text format     Abstract available
    
    
    
12. LEE S, Kang DH, Kim DH, Song JM, et al
    Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.
    Am Heart J. 2017;194:1-8.
    PubMed     Text format     Abstract available
    
    
    October 2017
13. MOJOLI M, Gersh BJ, Barioli A, Masiero G, et al
    Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Am Heart J. 2017;192:64-75.
    PubMed     Text format     Abstract available
    
    
    
14. KESSLER M, Gonska B, Seeger J, Rottbauer W, et al
    Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Am Heart J. 2017;192:57-63.
    PubMed     Text format     Abstract available
    
    
    July 2017
15. VEMULAPALLI S, Lippmann SJ, Krucoff M, Hernandez AF, et al
    Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients.
    Am Heart J. 2017;189:146-157.
    PubMed     Text format     Abstract available
    
    
    
16. ROGERS T, Torguson R, Bastian R, Corso P, et al
    Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study.
    Am Heart J. 2017;189:103-109.
    PubMed     Text format     Abstract available
    
    
    June 2017
17. GOLDBERG SL, Meredith I, Marwick T, Haluska BA, et al
    A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study.
    Am Heart J. 2017;188:167-174.
    PubMed     Text format     Abstract available
    
    
    May 2017
18. ARENDT CJ, Hong JH, Daly RC, Scott C, et al
    Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery.
    Am Heart J. 2017;187:70-77.
    PubMed     Text format     Abstract available
    
    
    
19. HO CY, McMurray JJV, Cirino AL, Colan SD, et al
    The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial.
    Am Heart J. 2017;187:145-155.
    PubMed     Text format     Abstract available
    
    
    March 2017
20. KLECZYNSKI P, Dziewierz A, Bagienski M, Rzeszutko L, et al
    Impact of frailty on mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;185:52-58.
    PubMed     Text format     Abstract available
    
    
    February 2017
21. MARTIN GP, Sperrin M, Ludman PF, de Belder MA, et al
    Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation.
    Am Heart J. 2017;184:97-105.
    PubMed     Text format     Abstract available
    
    
    
22. KOIFMAN E, Didier R, Patel N, Jerusalem Z, et al
    Impact of right ventricular function on outcome of severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2017;184:141-147.
    PubMed     Text format     Abstract available
    
    
    
23. SORENSEN LL, Liang HY, Pinheiro A, Hilser A, et al
    Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Am Heart J. 2017;184:47-54.
    PubMed     Text format     Abstract available
    
    
    December 2016
24. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available
    
    
    
25. PRESSLER A, Christle JW, Lechner B, Grabs V, et al
    Exercise training improves exercise capacity and quality of life after transcatheter aortic valve implantation: A randomized pilot trial.
    Am Heart J. 2016;182:44-53.
    PubMed     Text format     Abstract available
    
    
    
26. DAHYA V, Xiao J, Prado CM, Burroughs P, et al
    Computed tomography-derived skeletal muscle index: A novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:21-27.
    PubMed     Text format     Abstract available
    
    
    
27. CHAUHAN D, Haik N, Merlo A, Haik BJ, et al
    Quantitative increase in frailty is associated with diminished survival after transcatheter aortic valve replacement.
    Am Heart J. 2016;182:146-154.
    PubMed     Text format     Abstract available
    
    
    October 2016
28. WINDECKER S, Tijssen J, Giustino G, Guimaraes AH, et al
    Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
    Am Heart J. 2016;184:81-87.
    PubMed     Text format     Abstract available
    
    
    
29. VOLLENBROICH R, Stortecky S, Praz F, Lanz J, et al
    The impact of functional vs degenerative mitral regurgitation on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2016;184:71-80.
    PubMed     Text format     Abstract available
    
    
    September 2016
30. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Text format     Abstract available
    
    
    August 2016
31. BANOVIC M, Iung B, Bartunek J, Penicka M, et al
    Response: Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in "the world of AVATAR".
    Am Heart J. 2016;178:e3-4.
    PubMed     Text format    
    
    
    
32. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P
    Asymptomatic severe aortic stenosis: Cardiopulmonary exercise testing in "The World of AVATAR".
    Am Heart J. 2016;178:e1.
    PubMed     Text format    
    
    
    
33. ABATE E, Hoogslag GE, Al Amri I, Debonnaire P, et al
    Time course, predictors, and prognostic implications of significant mitral regurgitation after ST-segment elevation myocardial infarction.
    Am Heart J. 2016;178:115-25.
    PubMed     Text format     Abstract available
    
    
    
34. KIRAMIJYAN S, Magalhaes MA, Koifman E, Didier R, et al
    Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.
    Am Heart J. 2016;178:19-27.
    PubMed     Text format     Abstract available
    
    
    
35. MARTINS RP, Galand V, Colette E, Behar N, et al
    Defining nonvalvular atrial fibrillation: A quest for clarification.
    Am Heart J. 2016;178:161-7.
    PubMed     Text format     Abstract available
    
    
    July 2016
36. DAYOUB EJ, Nallamothu BK
    Geographic access to transcatheter aortic valve replacement relative to other invasive cardiac services: A statewide analysis.
    Am Heart J. 2016;177:163-70.
    PubMed     Text format     Abstract available
    
    
    
37. BAKKESTROM R, Larsen LA, Moller JE, Videbaek L, et al
    Mitral valve regurgitation in twins: Concordance and survival.
    Am Heart J. 2016;177:51-7.
    PubMed     Text format     Abstract available
    
    
    May 2016
38. DOBSON LE, Fairbairn TA, Musa TA, Uddin A, et al
    Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study.
    Am Heart J. 2016;175:101-11.
    PubMed     Text format     Abstract available
    
    
    April 2016
39. BANOVIC M, Iung B, Bartunek J, Asanin M, et al
    Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial.
    Am Heart J. 2016;174:147-53.
    PubMed     Text format     Abstract available
    
    
    March 2016
40. ESCARCEGA RO, Baker NC, Lipinski MJ, Koifman E, et al
    Clinical profiles and correlates of mortality in nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Am Heart J. 2016;173:118-25.
    PubMed     Text format     Abstract available
    
    
    
41. NIJENHUIS VJ, Bennaghmouch N, Hassell M, Baan J Jr, et al
    Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation.
    Am Heart J. 2016;173:77-85.
    PubMed     Text format     Abstract available
    
    
    February 2016
42. WANG A, Grayburn P, Foster JA, McCulloch ML, et al
    Practice gaps in the care of mitral valve regurgitation: Insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel.
    Am Heart J. 2016;172:70-9.
    PubMed     Text format     Abstract available
    
    
    November 2015
43. VELAZQUEZ EJ, Samad Z, Al-Khalidi HR, Sangli C, et al
    The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison.
    Am Heart J. 2015;170:1050-1059.
    PubMed     Text format     Abstract available
    
    
    October 2015
44. GOTZMANN M, Knoop H, Ewers A, Mugge A, et al
    Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: Insights from spirometry and body plethysmography.
    Am Heart J. 2015;170:837-842.
    PubMed     Text format     Abstract available
    
    
    
45. SINNING JM, Wollert KC, Sedaghat A, Widera C, et al
    Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
    Am Heart J. 2015;170:821-9.
    PubMed     Text format     Abstract available
    
    
    August 2015
46. OZKAN M, Gunduz S, Gursoy OM, Karakoyun S, et al
    Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
    Am Heart J. 2015;170:409-18.
    PubMed     Text format     Abstract available
    
    
    
47. KRAMER CM, Appelbaum E, Desai MY, Desvigne-Nickens P, et al
    Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.
    Am Heart J. 2015;170:223-30.
    PubMed     Text format     Abstract available
    
    
    July 2015
48. CAPODANNO D, Adamo M, Barbanti M, Giannini C, et al
    Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair.
    Am Heart J. 2015;170:187-95.
    PubMed     Text format     Abstract available
    
    
    
49. CHRISTODOULIDIS G, Yu J, Kini A, Dangas GD, et al
    Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes.
    Am Heart J. 2015;170:180-6.
    PubMed     Text format     Abstract available
    
    
    
50. PAULEY E, Lishmanov A, Schumann S, Gala GJ, et al
    Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in the cardiac intensive care unit.
    Am Heart J. 2015;170:79-86.
    PubMed     Text format     Abstract available
    
    
    May 2015
51. MASRI A, Pierson LM, Smedira NG, Agarwal S, et al
    Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
    Am Heart J. 2015;169:684-692.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: